These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7349819)

  • 1. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Int J Chronobiol; 1980; 7(2):101-15. PubMed ID: 7450919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultradian (12-hr) significant component in serum prolactin of healthy women and patients with fibrocystic mastopathy.
    D'Allesandro B; Esposito V; Lo Iudice G; Cagnoni M; Tarquini B
    Prog Clin Biol Res; 1987; 227B():281-4. PubMed ID: 3628338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward chronobiologic pattern discrimination of the risk of developing breast cancer and other diseases.
    Hermida Domínguez RC; Halberg F; del Pozo F; Haus E
    Rev Esp Oncol; 1982; 29(2):199-267. PubMed ID: 6765184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible linkage between the ability to change the period (tau) of the prolactin and cortisol rhythms in women and breast cancer risk.
    Lewy H; Haus E; Ashkenazi IE
    Chronobiol Int; 2007; 24(2):365-81. PubMed ID: 17453854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin levels in patients with fibrocystic breast disease.
    Peters F; Schuth W; Scheurich B; Breckwoldt M
    Obstet Gynecol; 1984 Sep; 64(3):381-5. PubMed ID: 6431348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolactin in serum and anamnestic data of women with cystic disease of the breast (author's transl)].
    Bischoff J; Rebhan EM; Prestele H; Becker H
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):65-71. PubMed ID: 7353778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C; Ferrer S; Merle S; Sanchis V; Camps Roig J; Giménez Climent J
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the risk of mesor-hypertension.
    Hermida-Dominguez RC; Halberg F
    Chronobiologia; 1984; 11(3):249-62. PubMed ID: 6510120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
    Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
    Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian mesor-hyperprolactinemia in fibrocystic mastopathy.
    Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
    Am J Med; 1979 Feb; 66(2):229-37. PubMed ID: 425966
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China.
    Lampe JW; Nishino Y; Ray RM; Wu C; Li W; Lin MG; Gao DL; Hu Y; Shannon J; Stalsberg H; Porter PL; Frankenfeld CL; Wähälä K; Thomas DB
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2579-86. PubMed ID: 18086761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circadian and circumannual variations in the level of plasma TSH and prolactin in healthy adult males].
    Guagnano MT; Angelucci E; Del Ponte A; Boni R; Sensi S
    Boll Soc Ital Biol Sper; 1984 Nov; 60(11):2039-45. PubMed ID: 6525257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrocystic disease of breast and pituitary-thyroid axis function].
    Zych F; Mizia-Stec K; Mucha Z; Zych-Twardowska E
    Pol Merkur Lekarski; 1996 Oct; 1(4):227-8. PubMed ID: 9156929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
    Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J
    Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast].
    Korolev VI; Skliar SIu; Ponomarev IN
    Vrach Delo; 1988 Jan; (1):59-61. PubMed ID: 3363942
    [No Abstract]   [Full Text] [Related]  

  • 20. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease.
    Schrauzer GN; Molenaar T; Mead S; Kuehn K; Yamamoto H; Araki E
    Jpn J Cancer Res; 1985 May; 76(5):374-7. PubMed ID: 3924710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.